• OPEN AN ACCOUNT
Indian Indices
Nifty
25,330.25 91.15
(0.36%)
Sensex
82,782.75 89.04
( 0.11%)
Bank Nifty
55,493.30 345.70
( 0.63%)
Nifty IT
36,447.15 235.00
( 0.65%)
Global Indices
Nasdaq
46,015.42 236.51
(0.52%)
Dow Jones
6,617.88 9.88
(-0.15%)
Hang Seng
45,342.39 552.01
(1.23%)
Nikkei 225
9,208.37 12.71
(0.14%)
Forex
USD-INR
88.02 0.00
(0.00%)
EUR-INR
104.02 0.00
(0.00%)
GBP-INR
120.02 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
68.76
160625.75
EPS(TTM)
Face Value()
Div & Yield %
88
2
0.49
 

sri rpp infra projects ltd
Avantel spurts on bagging order worth Rs 44 cr from Larsen & Toubro
Sep 30,2024
Shares of Larsen & Toubro (L&T) fell 0.33% to currently trade at Rs 3,693.45 on the BSE.

The contract includes supply of satcom systems. The said contract is expected to be executed by March 2025.

Avantel specializes in providing strategic solutions to the Indian Defence Services and related establishments. It has developed and manufactured various radio components and unique products such as satellite communications, HF communications, electronic warfare, and radar systems. Currently, Avantel is working on expanding its portfolio by developing SCA-compliant software defined radios, high power HF systems, air defence radars, and small satellites.

The company's consolidated net profit declined 7.9% to Rs 7.38 crore on 24.9% fall in net sales to Rs 51.76 crore in Q1 FY25 over Q1 FY24.